Principles of contrast enhancement in the evaluation of brain diseases: An overview

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 1, 1997, Pages 5-13

  Runge, Val M ^a   Muroff, Lawrence R ^b,c   Wells, John W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Brain, diseases; Brain, MR; Gadolinium; MR, contrast enhancement

Indexed keywords

GADOLINIUM CHELATE;

BRAIN DISEASE; BRAIN INFECTION; BRAIN INJURY; BRAIN METASTASIS; BRAIN TUMOR; CEREBROVASCULAR DISEASE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG SAFETY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION NECROSIS; REVIEW;

BRAIN DISEASES; BRAIN NEOPLASMS; CEREBROVASCULAR DISORDERS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; ENCEPHALITIS; HUMANS; IMAGE ENHANCEMENT; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY;

EID: 0031421952     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070103     Document Type: Review

References (24)

1. Muroff LR, Runge VM. The use of MR contrast in neoplastic disease of the brain. Top Magn Reson Imaging 1995; 7:137-157.
2. Runge VM. The use of MR contrast in nonneoplastic disease of the brain. Top Magn Reson Imaging 1995; 7:158-167.
3. Tweedle MF. Physico-chemical properties of gadoteridol and other magnetic resonance contrast agents. Invest Radiol 1992; 27:S2-S6.
4. Figueroa RE, El Gammal T, Brook BS, et al. MR findings in primitive neuroectodermal tumors. J Comput Assist Tomogr 1989; 13:773-778.
5. Poon T, Matoso I, Tchertkoff V, et al. CT features of primary cerebral lymphoma in AIDS and non-AIDS patients. J Comput Assist Tomogr 1989; 13:6-9.
6. Schwaighofer BW, Hesselink JR, Press GA, et al. Primary intracranial CNS lymphoma: MR manifestations. AJNR Am J Neuroradiol 1989; 10:725-729.
7. Hubschmann OR, Vijayanathan T, Countee RW. Von Hippel-Lindau disease with multiple manifestations: diagnosis and management. Neurosurgery 1981; 8:92-95.
8. Stack JP, Ramsden RT, Antoun NM, et al. Magnetic resonance imaging of acoustic neuromas: the role of gadolinium DTPA. Br J Radiol 1988; 61:800-805.
9. Haughton VM, Rimm AA, Czervionke LF, et al. Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors. Radiology 1988; 166:829-833.
10. Elster AD, Challa VR, Gilbert TH, et al. Meningiomas: MR and histopathologic features. Radiology 1989; 170:857-862.
11. Doppman JL, Frank JA, Dwyer AJ, et al. Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland. J Comput Assist Tomogr 1988; 12:728-735.
12. Davis PC, Friedman NC, Fry SN, et al. Leptomeningeal metastases: MR imaging. Radiology 1987; 163:449-454.
13. Volk PE, Dillon WP. Radiation injury of the brain. AJNR Am J Neuroradiol 1991; 12:45-52.
14. Ramsey R, Geremia G. CNS complications of AIDS: CT and MR findings. AJR Am J Roentgenol 1988; 151:449-454.
15. Castillo M. Brain infections in human immunodeficiency virus positive patients. Top Magn Reson Imaging 1994; 6:3-10.
16. Tuite M, Ketonen L, Kieburtz K, Handy B. Efficacy of gadolinium in MR brain imaging of HIV infected patients. AJNR Am J Neuroradiol 1993; 14:257-263.
17. Runge VM, Clanton JA, Price AC, et al. Evaluation of contrast enhanced MR imaging in a brain abscess model. AJNR Am J Neuroradiol 1985; 6:139-147.
18. Chang KH, Han MH, Roh JK, et al. Gd DTPA enhanced MR imaging of the brain in patients with meningitis: comparison with CT. AJR Am J Roentgenol 1990; 154:809-816.
19. Lee YY, Tien RD, Bruner JM, et al. Loculated intracranial leptomeningeal metastases: CT and MR characteristics. AJR Am J Roentgenol 1990; 154:351-359.
20. Wilms G, Demaerel P, Marchai G, et al. Gadolinium enhanced MR imaging of cerebral venous angiomas with emphasis on their drainage. J Comput Assist Tomogr 1991; 15:199-206.
21. Elster AD, Moody DM. Early cerebral infarction: gadopentetate dimeglumine enhancement. Radiology 1990; 177:627-632.
22. Runge VM, Kirsch JE, Wells JW, et al. Visualization of blood-brain barrier disruption on MR images of cats with acute cerebral infarction: value of administering a high dose of contrast material. AJR Am J Roentgenol 1994; 162:431-435.
23. Regli L, Regli F, Maeder P, Bogousslavsky J. Magnetic resonance imaging with gadolinium contrast agent in small deep (lacunar) cerebral infarcts. Arch Neurol 1993; 50:175-180.
24. Kermode AG, Thompson AJ, Tofts P, et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis: pathogenetic and clinical implications. Brain 1990; 113:1477-1489.